AP
amanda przespolewski
Cell Therapy, Bristol Myers Squibb
United States
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia
Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia
3,865
Total downloads
11k
Total views and downloads
35 Authors
- FW
feiqiu wen
Department of Hematology and Oncology, Shenzhen Children’s Hospital
China
- HY
hai yi
Department of Hematology, The General Hospital of Western Theater Command, PLA
China
- HY
hao yao
Department of Hematology, The General Hospital of Western Theater Command, PLA
China
- HM
huirong mai
Department of Hematology and Oncology, Shenzhen Children’s Hospital
China
- LW
lulu wang
Department of Hematology and Oncology, Shenzhen Children’s Hospital
China
- MB
matthew burwinkel
Department of Internal Medicine, University at Buffalo
United States
- SB
sawyer bawek
Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center
United States
- SL
sixi liu
Department of Hematology and Oncology, Shenzhen Children’s Hospital
China
- TL
tonghui li
Department of Hematology and Oncology, Shenzhen Children’s Hospital
China
- YS
yi su
Department of Hematology, The General Hospital of Western Theater Command, PLA
China
- YL
yifan liu
Medical School of Chinese PLA, Department of Hematology in the Fifth Medical Center of PLA General Hospital
China
